Schrodinger Gets Additional Gates Grant to Expand Predictive Toxicology Platform

MT Newswires Live11-18

Schrodinger (SDGR) said Monday it received an additional $9.5 million from the Bill & Melinda Gates Foundation to accelerate its initiative to expand its computational platform for early toxicology risk prediction in drug discovery.

The additional funding, which follows the initial $10 million grant from the foundation in July, enables Schrodinger to access relevant experimental structures faster and extends the funding for the initiative to April 2026, Schrodinger said.

The company said the initiative aims to reduce development failures and improve drug safety, and once developed, the technology will be available to Gates Foundation grantees and Schrodinger's customers.

The majority of revenue related to the additional funding is anticipated to be recognized next year, the company said.

Schrodinger shares were down more than 5% in recent Monday trading.

Price: 17.55, Change: -0.99, Percent Change: -5.34

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2484710946?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-18 23:17","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2484710946","market":"hk","top_or_hot":-1,"title":"Schrodinger Gets Additional Gates Grant to Expand Predictive Toxicology Platform","media":"MT Newswires Live","content":"<html><body><p> Schrodinger (SDGR) said Monday it received an additional $9.5 million from the Bill &amp; Melinda Gates Foundation to accelerate its initiative to expand its computational platform for early toxicology risk prediction in drug discovery.</p><p>The additional funding, which follows the initial $10 million grant from the foundation in July, enables Schrodinger to access relevant experimental structures faster and extends the funding for the initiative to April 2026, Schrodinger said.</p><p>The company said the initiative aims to reduce development failures and improve drug safety, and once developed, the technology will be available to Gates Foundation grantees and Schrodinger's customers.</p><p>The majority of revenue related to the additional funding is anticipated to be recognized next year, the company said.</p><p>Schrodinger shares were down more than 5% in recent Monday trading.</p><p>Price: 17.55, Change: -0.99, Percent Change: -5.34</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Schrodinger Gets Additional Gates Grant to Expand Predictive Toxicology Platform</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSchrodinger Gets Additional Gates Grant to Expand Predictive Toxicology Platform\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-18 23:17 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Schrodinger (SDGR) said Monday it received an additional $9.5 million from the Bill & Melinda Gates Foundation to accelerate its initiative to expand its computational platform for early toxicology ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SDGR","symbol_name":"Schrodinger Inc.","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2484710946","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2484710946","pubTimestamp":1731943028,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Schrodinger  said Monday it received an additional $9.5 million from the Bill & Melinda Gates Foundation to accelerate its initiative to expand its computational platform for early toxicology risk prediction in drug discovery.The additional funding, which follows the initial $10 million grant from the foundation in July, enables Schrodinger to access relevant experimental structures faster and extends the funding for the initiative to April 2026, Schrodinger said.The company said the initiative aims to reduce development failures and improve drug safety, and once developed, the technology will be available to Gates Foundation grantees and Schrodinger's customers.The majority of revenue related to the additional funding is anticipated to be recognized next year, the company said.Schrodinger shares were down more than 5% in recent Monday trading.Price: 17.55, Change: -0.99, Percent Change: -5.34","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SDGR":"Schrodinger Inc.","BK4167":"医疗保健技术","BK4588":"碎股","BK4585":"ETF&股票定投概念"},"translate_title":"薛定谔获得额外盖茨拨款以扩展预测毒理学平台","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SDGR":1},"content_text":"Schrodinger (SDGR) said Monday it received an additional $9.5 million from the Bill & Melinda Gates Foundation to accelerate its initiative to expand its computational platform for early toxicology risk prediction in drug discovery.The additional funding, which follows the initial $10 million grant from the foundation in July, enables Schrodinger to access relevant experimental structures faster and extends the funding for the initiative to April 2026, Schrodinger said.The company said the initiative aims to reduce development failures and improve drug safety, and once developed, the technology will be available to Gates Foundation grantees and Schrodinger's customers.The majority of revenue related to the additional funding is anticipated to be recognized next year, the company said.Schrodinger shares were down more than 5% in recent Monday trading.Price: 17.55, Change: -0.99, Percent Change: -5.34","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2484710946"}